Graham, Garry G <br/><br/>
FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable?  [electronic resource] 

 -  Inflammopharmacology  Apr 2010 
 - 47-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1568-5608 
<br/><br/><label>Standard No.: </label>10.1007/s10787-010-0036-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetaminophen--administration & dosage<br/>Advisory Committees<br/>Alcohol Drinking--adverse effects<br/>Analgesics, Opioid--administration & dosage<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Chemical and Drug Induced Liver Injury--prevention & control<br/>Drug Combinations<br/>Drug Labeling--legislation & jurisprudence<br/>Drug Packaging--legislation & jurisprudence<br/>Drug and Narcotic Control<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Humans<br/>Nonprescription Drugs--administration & dosage<br/>Pain--drug therapy<br/>Prescription Drugs--administration & dosage<br/>United States<br/>United States Food and Drug Administration